论文部分内容阅读
目的探讨血液净化联合复方α-酮酸治疗尿毒症的临床疗效。方法选取2007年05月至2011年04月就就诊于我院的109例尿毒症患者作为研究对象,随机分为观察组54例(血液净化联合复方α-酮酸方案治疗),对照组55例(血液净化治疗),回顾性分析两组患者的临床疗效。结果观察组总有效率为94.4%;对照组总有效率为83.7%,两组治疗效果经统计分析,差异具有统计学意义(P<0.05)。结论血液净化联合复方α-酮酸方案治疗尿毒症效果显著,建议临床治疗多加关注。
Objective To investigate the clinical efficacy of blood purification combined with α-keto acid in the treatment of uremia. Methods A total of 109 uremic patients treated in our hospital from May 2007 to April 2011 were selected and randomly divided into observation group (n = 54) (blood purification plus compound a-keto acid regimen) and control group (n = 55) (Blood purification treatment), a retrospective analysis of the clinical efficacy of two groups of patients. Results The total effective rate was 94.4% in the observation group and 83.7% in the control group. The treatment effect was statistically significant between the two groups (P <0.05). Conclusion Blood purification combined with compound α-keto acid regimen has significant effect in treating uremia. It is suggested that more attention should be paid to clinical treatment.